HCV-3a isolates and sequence homology of more than 85% for all isolates [ Figure 1 ]. Similarly, the remaining three HCV-3b isolates from Uttarakhand also clustered with Canadian HCV-3b isolates with more than 86% identity at nucleotide level for all isolates [ Figure 1 ]. The Uttarakhand HCV isolates when compared with each other were found to have more sequence similarities except one isolate (HCV-3a/UKD-2/India) which showed lower sequence identity with other HCV 3a isolates.
In our study, out of 33 patients who were HCV positive by PCR assay, 28 (84.8%) were from Udham Singh Nagar (USN) district and the remaining 5 (15.2%) were from the Nainital District. In our previous study from this region on blood donors, signifi cantly higher HCV seropositivity was seen among the Sikh population from the USN district. [5] USN is largely inhabited by the Sikh community, where many people are found to be associated in some form of working or visiting Canada. It is hypothesised that this could be the reason for the close association of Indian and Canadian HCV isolates. However, a larger cohort from this geographical region is required to test the hypothesis that this genotype may have spread from Canada to USN place via population migration and admixture.
Mucor-culture/molecular analysis necessary for identifi cation
Dear Editor, This is with reference to a case report by Angeline, et al., [1] 'Subcutaneous Mucor Zygomycosis with potential life threatening visceral complication', published in the Indian J Med Microbiol 2013;31 (2):182-4. We have some reservations regarding use of the word 'Mucor' in the title.
The authors have described a case of subcutaneous zygomycosis. Taxonomic organisation of zygomycetes has been described in a review by Ribes et al., [2] and in greater detail by Hoffman et al. [3] Mucor is one of the 57 genera of the order-Mucorales of the phylum Zygomycota. [3] The fi ndings in the case report included involvement of subcutaneous site and presence of eosinophilic granuloma that is Splendore Hoeppli phenomenon. These fi ndings are commonly seen in infections due to Entomophthorales but rarely with Mucorales. [2] Response to fl uconazole therapy has been described before for Entomophthorales [4] whereas resistance has been reported consistently against Mucorales. [5] Though the patient Indian Journal of Medical Microbiology S164 vol. 33, Supplement 1 www.ijmm.org responded to fl uconazole therapy and the authors have described it as an exception; in the absence of a culture report or molecular analysis, it may not be appropriate to label it as a case of 'Mucor' or 'Mucorales' as it may prompt the readers to use fl uconazole for the treatment of other 'Mucor' infections.
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China
Dear Editor, Tuberculosis (TB) has been a major health problem all over the world and China has the second highest prevalence of TB in the world. In China, multidrug-resistant (MDR) and extensively drug-resistant (XDR) M. tuberculosis strains represents a serious public health concern. [1] These have led to demand for new anti-tuberculosis drugs. Linezolid, the fi rst oxazolidinone antibiotics has been reported has the antituberculosis activity and may be used to treat MDR M. tuberculosis isolates. [2, 3] We tested the in vitro activity of linezolid against 61 clinical strains of M. tuberculosis isolated from Shenyang Chest Hospital using the agar proportion method. Linezolid was provided by Pfi zer (Zyvox ® ; Pfi zer Inc., New York, NY, USA). The drug susceptibility test results of the 61 strains were 21 (34.4%) susceptible, 7 (11.5%) monoresistant to INH, 3 (4.9%) polyresistant to INH and OFL, 20 (32.8%) MDR-TB and 10 (16.4%) XDR-TB [ Table 1 ]. The MICs of linezolid for the 61 strains are 0.125 -1 g/mL including 20 MDR-TB and 10 XDR-TB strains. This is lower than that of Prammananan et al. have reported. [4] And we did not fi nd the strains which were resistance to linezolid. There were no differences in MIC 50 of linezolid among the groups, which were 0.25 g/mL. Linezolid MIC 90 of XDR group was higher than that of the other groups, which were 0.5 g/m and 0.25 g/mL respectively [ Table 1 ] Our results suggest that linezolid has excellent activity against M. tuberculosis including MDR and XDR strains in China. Previously we have reported the clinical symptoms improved in three pulmonary TB patients (1 confi rmed and 2 suspected) treating with linezolid . [5] Because of the gastrointestinal and haematological adverse reactions of linezolid for long period used, we think that linezolid may be recommended for the treatment of XDR-TB with the other drugs in combination regimen with half of the routine doses.
